ADARx Pharmaceuticals (ADRX) vs Schrodinger (SDGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Schrodinger is the larger company by market cap ($2.04 billion vs $1.85 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | SDGR |
|---|---|---|
| Share price | $17.33 | $27.29 |
| Market cap | $1.85B | $2.04B |
| 1-day change | -6.73% | -5.57% |
| YTD return | — | +52.63% |
| 1-year return | — | +35.37% |
| 5-year return | — | -50.70% |
| EPS (TTM) | $-1.16 | $-0.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.21 | $33.78 |
| 52-week low | $17.20 | $10.95 |
| Distance from 52-week high | -25.33% | -19.21% |
| Analyst consensus | — | none |
| Avg. price target upside | — | -21.47% |
| Average volume | 1.42M | 1.69M |
| Shares outstanding | 106.80M | 65.64M |
| Employees | 100 | 850 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Schrodinger
SDGR stock →Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.
Health Care · Biotechnology: Pharmaceutical Preparations · 850 employees
ADRX vs SDGR FAQ
Which is bigger, ADARx Pharmaceuticals or Schrodinger?
Schrodinger (SDGR) is larger, with a market capitalization of $2.04B compared with $1.85B for ADARx Pharmaceuticals (ADRX).
Are ADARx Pharmaceuticals and Schrodinger in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.